200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 43135-91-7
43135-91-7 | benzimidazol-2-one
CAS No: 43135-91-7 Catalog No: AG00DJVX MDL No:
Product Description
Catalog Number:
AG00DJVX
Chemical Name:
benzimidazol-2-one
CAS Number:
43135-91-7
IUPAC Name:
benzimidazol-2-one
InChI:
InChI=1S/C7H4N2O/c10-7-8-5-3-1-2-4-6(5)9-7/h1-4H
InChI Key:
MYONAGGJKCJOBT-UHFFFAOYSA-N
Properties
Complexity:
278
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
132.032g/mol
Formal Charge:
0
Heavy Atom Count:
10
Hydrogen Bond Acceptor Count:
1
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
132.122g/mol
Monoisotopic Mass:
132.032g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
41.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.4
Literature
| Title | Journal |
|---|---|
| Searching for novel N(1)-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitors. | Bioorganic & medicinal chemistry 20170715 |
| Design of oxobenzimidazoles and oxindoles as novel androgen receptor antagonists. | Bioorganic & medicinal chemistry letters 20120401 |
| 5-Nitro-1-(prop-2-yn-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one. | Acta crystallographica. Section E, Structure reports online 20120401 |
| 1,3-Bis[2-hy-droxy-2-(6-meth-oxy-2,2-dimethyl-3a,5,6,6a-tetra-hydro-2H-furo[2,3-d][1,3]dioxol-5-yl)eth-yl]-2,3-dihydro-1H-1,3-benzodiazol-2-one. | Acta crystallographica. Section E, Structure reports online 20120201 |
| Synthesis and antibacterial activities of 1-alkyl-3-methacryloyl (acryloyl) of benzimidazolone (thione) derivatives. | International journal of molecular sciences 20120101 |
| Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators. | Journal of medicinal chemistry 20111222 |
| Effect of nitro groups on the photo physical properties of benzimidazolone: a solvatochromic study. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111215 |
| Synthesis and Diels-Alder cycloadditions of exo-imidazolidin-2-one dienes. | The Journal of organic chemistry 20111007 |
| Receptor-based QSAR study for a series of 3,3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors. | SAR and QSAR in environmental research 20111001 |
| Benzimidazolone as potent chymase inhibitor: modulation of reactive metabolite formation in the hydrophobic (P1) region. | Bioorganic & medicinal chemistry letters 20110801 |
| 5-Chloro-1-[(E)-3-(dimethyl-amino)-acrylo-yl]-3-methyl-1H-benzimidazol-2(3H)-one-6-chloro-1-[(E)-3-(dimethyl-amino)-acrylo-yl]-3-methyl-1H-benzimid-azol-2(3H)-one (4/1). | Acta crystallographica. Section E, Structure reports online 20110701 |
| Potassium hydroxide/dimethyl sulfoxide promoted intramolecular cyclization for the synthesis of benzimidazol-2-ones. | Organic letters 20110603 |
| The identification of synthetic organic pigments in modern paints and modern paintings using pyrolysis-gas chromatography-mass spectrometry. | Analytical and bioanalytical chemistry 20110501 |
| 5-Nitro-1-n-octyl-1H-benzimidazol-2(3H)-one. | Acta crystallographica. Section E, Structure reports online 20110301 |
| 1-n-Decyl-5-nitro-1H-benzimidazol-2(3H)-one. | Acta crystallographica. Section E, Structure reports online 20110301 |
| 5-Nitro-1-nonyl-1H-benzimidazol-2(3H)-one. | Acta crystallographica. Section E, Structure reports online 20110301 |
| 1,3-Diallyl-5-chloro-1H-benzimidazol-2(3H)-one. | Acta crystallographica. Section E, Structure reports online 20110201 |
| Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies. | Frontiers in pharmacology 20110101 |
| Stimulation of Wild-Type, F508del- and G551D-CFTR Chloride Channels by Non-Toxic Modified pyrrolo[2,3-b]pyrazine Derivatives. | Frontiers in pharmacology 20110101 |
| The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients. | PloS one 20110101 |
| N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors. | Bioorganic & medicinal chemistry letters 20101215 |
| Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK(Ca)) channel opening. | Pain 20101001 |
| Validation of experimental molecular crystal structures with dispersion-corrected density functional theory calculations. | Acta crystallographica. Section B, Structural science 20101001 |
| Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules. | Journal of medicinal chemistry 20100624 |
| Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation. | Antiviral research 20100601 |
| Rapid access towards follow-up NOP receptor agonists using a knowledge based approach. | Bioorganic & medicinal chemistry letters 20091115 |
| 1,3-Bis(hydroxy-meth-yl)benzimidazolin-2-one. | Acta crystallographica. Section E, Structure reports online 20091101 |
| 1-(2-Bromo-benz-yl)-3-isopropyl-benz-imid-azolin-2-one. | Acta crystallographica. Section E, Structure reports online 20091101 |
| 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors. | Journal of medicinal chemistry 20090924 |
| Synthetic organic pigments of the 20th and 21st century relevant to artist's paints: Raman spectra reference collection. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090801 |
| Design and synthesis of isoform-selective phospholipase D (PLD) inhibitors. Part I: Impact of alternative halogenated privileged structures for PLD1 specificity. | Bioorganic & medicinal chemistry letters 20090401 |
| Structures of six industrial benzimidazolone pigments from laboratory powder diffraction data. | Acta crystallographica. Section B, Structural science 20090401 |
| Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation. | Bioorganic & medicinal chemistry letters 20090315 |
| Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. | PLoS biology 20090101 |
| 6-Chloro-1-(3,5-dimethyl-phenyl-sulfon-yl)-1H-benzimidazol-2(3H)-one. | Acta crystallographica. Section E, Structure reports online 20090101 |
| Potent benzimidazolone-based CGRP receptor antagonists. | Bioorganic & medicinal chemistry letters 20081201 |
| Molecular and cellular basis of small--and intermediate-conductance, calcium-activated potassium channel function in the brain. | Cellular and molecular life sciences : CMLS 20081001 |
| Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors. | Bioorganic & medicinal chemistry 20080801 |
| The SAR studies of novel CB2 selective agonists, benzimidazolone derivatives. | Bioorganic & medicinal chemistry letters 20080601 |
| Modulators of ion transport in nasal polyps: an in situ measurement of short-circuit current. | Clinical and experimental otorhinolaryngology 20080601 |
| Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties. | Bioorganic & medicinal chemistry 20080315 |
| Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery. | The AAPS journal 20080301 |
| Towards the synthesis of new benzimidazolone derivatives with surfactant properties. | Carbohydrate research 20080225 |
| Raman identification of yellow synthetic organic pigments in modern and contemporary paintings: reference spectra and case studies. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20080201 |
| Structural elucidation of rabeprazole sodium photodegradation products. | Journal of pharmaceutical and biomedical analysis 20080107 |
| New 'chemical probes' to examine the role of the hFPRL1 (or ALXR) receptor in inflammation. | Bioorganic & medicinal chemistry letters 20071201 |
| Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties. | Bioorganic & medicinal chemistry 20070215 |
| Solution-phase parallel synthesis of 2,3-dihydro-1,5-benzothiazepin-4(5H)-ones. | Journal of combinatorial chemistry 20070101 |
| Discovery and design of benzimidazolone based inhibitors of p38 MAP kinase. | Bioorganic & medicinal chemistry letters 20061215 |
| Potent benzimidazolone based human beta(3)-adrenergic receptor agonists. | Bioorganic & medicinal chemistry letters 20061101 |
| Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo. | Bioorganic & medicinal chemistry letters 20060301 |
| Recent advances in the solid-phase combinatorial synthetic strategies for the quinoxaline, quinazoline and benzimidazole based privileged structures. | Mini reviews in medicinal chemistry 20060101 |
| Theoretical and experimental design of atypical kinase inhibitors: application to p38 MAP kinase. | Journal of medicinal chemistry 20050908 |
| SAR studies of 6-aryl-1,3-dihydrobenzimidazol-2-ones as progesterone receptor antagonists. | Bioorganic & medicinal chemistry letters 20050801 |
| Benzimidazolones and indoles as non-thiol farnesyltransferase inhibitors based on tipifarnib scaffold: synthesis and activity. | Bioorganic & medicinal chemistry letters 20050602 |
| Discovery and SAR studies of a novel series of noncovalent cathepsin S inhibitors. | Bioorganic & medicinal chemistry letters 20050315 |
| Multiple tandem mass spectrometry-based investigation of the behaviour of some thiazol-benzimidazolones and 2-benzimidazolylsulfanyl ethanones. | European journal of mass spectrometry (Chichester, England) 20050101 |
| Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime). | Biochimica et biophysica acta 20041011 |
| Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives. | Bioorganic & medicinal chemistry letters 20040308 |
| Benzimidazolone p38 inhibitors. | Bioorganic & medicinal chemistry letters 20040223 |
| Solid-phase convergent synthesis of a benzimidazolone library via the combination of two smaller arrays of carboxylic acids and secondary amines. | Journal of combinatorial chemistry 20040101 |
| Synthesis, radiosynthesis and in vivo evaluation of 5-[3-(4-benzylpiperidin-1-yl)prop-1-ynyl]-1,3-dihydrobenzoimidazol-2-[(11)C]one, as a potent NR(1A)/2B subtype selective NMDA PET radiotracer. | Bioorganic & medicinal chemistry 20031201 |
| Natural modulators of large-conductance calcium-activated potassium channels. | Planta medica 20031001 |
| Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004. | The Journal of membrane biology 20030715 |
| CFTR activation in human bronchial epithelial cells by novel benzoflavone and benzimidazolone compounds. | American journal of physiology. Lung cellular and molecular physiology 20030701 |
| Large-conductance K+ channel openers NS1619 and NS004 as inhibitors of mitochondrial function in glioma cells. | Biochemical pharmacology 20030601 |
| Rapid liquid-phase combinatorial synthesis of heterocyclic libraries. | Methods in molecular biology (Clifton, N.J.) 20020101 |
| Some structural changes on triazolyl-benzotriazoles and triazolyl-benzimidazolones as potential potassium channel activators. III. | Farmaco (Societa chimica italiana : 1989) 20011101 |
| Synthesis and progesterone receptor antagonist activities of 6-aryl benzimidazolones and benzothiazolones. | Bioorganic & medicinal chemistry letters 20011022 |
| A new synthetic approach to 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-ethyl-1,3-dihydro-benzimidazol-2-one(J-113397), the first non-peptide ORL-1 receptor antagonist. | Bioorganic & medicinal chemistry 20010701 |
| A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs. | The Journal of pharmacology and experimental therapeutics 20010201 |
| Benzimidazolone activators of chloride secretion: potential therapeutics for cystic fibrosis and chronic obstructive pulmonary disease. | The Journal of pharmacology and experimental therapeutics 20010201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.